Search research articles
Contact Us
Filters
Showing results (11-20 of 38) with videos related to
Page
of 4
Sort By:
Neuropsychiatric Disease and Treatment
|
October 1, 2019
A commentary on the efficacy of olanzapine for the treatment of schizophrenia: the past, present, and future
Leslie Citrome, Joseph P McEvoy, Mark S Todtenkopf, et al.
The Journal of Clinical Psychiatry
|
April 7, 2026
The Efficacy of Olanzapine/Samidorphan on Negative Symptoms: A Post Hoc Analysis of 56-Week Treatment in Patients With Schizophrenia
Roger S McIntyre, Desiree M Matthews, Christina Arevalo, et al.
The Journal of Clinical Psychiatry
|
May 3, 2008
An 8-week, double-blind, randomized, placebo-controlled study of olanzapine long-acting injection in acutely ill patients with schizophrenia
John Lauriello, Tim Lambert, Scott Andersen, et al.
CNS Spectrums
|
October 13, 2022
Olanzapine/samidorphan combination consistently mitigates weight gain across various subgroups of patients
Jonathan M Meyer, Adam Simmons, Ying Jiang, et al.
The Journal of Clinical Psychiatry
|
January 20, 2025
Olanzapine/Samidorphan Effects on Weight Gain: An Individual Patient Data Meta-Analysis of Phase 2 and 3 Randomized Double-Blind Studies
Christoph U Correll, Michael J Doane, David McDonnell, et al.
Neuropsychiatric Disease and Treatment
|
July 15, 2014
Long-term functional improvements in the 2-year treatment of schizophrenia outpatients with olanzapine long-acting injection
Haya Ascher-Svanum, Diego Novick, Josep Maria Haro, et al.
BMC Psychiatry
|
September 18, 2013
Predictors of psychiatric hospitalization during 6 months of maintenance treatment with olanzapine long-acting injection: post hoc analysis of a randomized, double-blind study
Haya Ascher-Svanum, Diego Novick, Josep Maria Haro, et al.
The International Journal of Neuropsychopharmacology
|
June 16, 2023
Weight Gain and Metabolic Changes in Patients With First-Episode Psychosis or Early-Phase Schizophrenia Treated With Olanzapine: A Meta-Analysis
Christoph U Correll, Mikkel Højlund, Christine Graham, et al.
Frontiers in Psychiatry
|
September 5, 2024
Using qualitative exit interviews to explore schizophrenia burden and treatment experience in clinical trial patients
Adam Simmons, Amy K O'Sullivan, Julia Carpenter-Conlin, et al.
The Mental Health Clinician
|
October 20, 2023
Comment on "Opioid antagonists to prevent olanzapine-induced weight gain: A systematic review"
Mark S Todtenkopf, Christoph U Correll, Marni E Harris-White, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 38) with videos related to
Sort By:
Page
of 4
Neuropsychiatric Disease and Treatment
|
October 1, 2019
A commentary on the efficacy of olanzapine for the treatment of schizophrenia: the past, present, and future
Leslie Citrome, Joseph P McEvoy, Mark S Todtenkopf, et al.
The Journal of Clinical Psychiatry
|
April 7, 2026
The Efficacy of Olanzapine/Samidorphan on Negative Symptoms: A Post Hoc Analysis of 56-Week Treatment in Patients With Schizophrenia
Roger S McIntyre, Desiree M Matthews, Christina Arevalo, et al.
The Journal of Clinical Psychiatry
|
May 3, 2008
An 8-week, double-blind, randomized, placebo-controlled study of olanzapine long-acting injection in acutely ill patients with schizophrenia
John Lauriello, Tim Lambert, Scott Andersen, et al.
CNS Spectrums
|
October 13, 2022
Olanzapine/samidorphan combination consistently mitigates weight gain across various subgroups of patients
Jonathan M Meyer, Adam Simmons, Ying Jiang, et al.
The Journal of Clinical Psychiatry
|
January 20, 2025
Olanzapine/Samidorphan Effects on Weight Gain: An Individual Patient Data Meta-Analysis of Phase 2 and 3 Randomized Double-Blind Studies
Christoph U Correll, Michael J Doane, David McDonnell, et al.
Neuropsychiatric Disease and Treatment
|
July 15, 2014
Long-term functional improvements in the 2-year treatment of schizophrenia outpatients with olanzapine long-acting injection
Haya Ascher-Svanum, Diego Novick, Josep Maria Haro, et al.
BMC Psychiatry
|
September 18, 2013
Predictors of psychiatric hospitalization during 6 months of maintenance treatment with olanzapine long-acting injection: post hoc analysis of a randomized, double-blind study
Haya Ascher-Svanum, Diego Novick, Josep Maria Haro, et al.
The International Journal of Neuropsychopharmacology
|
June 16, 2023
Weight Gain and Metabolic Changes in Patients With First-Episode Psychosis or Early-Phase Schizophrenia Treated With Olanzapine: A Meta-Analysis
Christoph U Correll, Mikkel Højlund, Christine Graham, et al.
Frontiers in Psychiatry
|
September 5, 2024
Using qualitative exit interviews to explore schizophrenia burden and treatment experience in clinical trial patients
Adam Simmons, Amy K O'Sullivan, Julia Carpenter-Conlin, et al.
The Mental Health Clinician
|
October 20, 2023
Comment on "Opioid antagonists to prevent olanzapine-induced weight gain: A systematic review"
Mark S Todtenkopf, Christoph U Correll, Marni E Harris-White, et al.
Page
of 4